CP and infection: In addition, there is a theoretical risk of antibody-dependent enhancement (ADE) (47), where previously-developed antibodies that are transfused worsen clinical severity as a result of infection with a different viral type, however, there have been no reports of ADE with use of CP in SARS-CoV or MERS infections (46).